Nephron Pharmaceuticals has announced a voluntary recall of ten lots of albuterol inhalation solution “as a precautionary measure, due to results from . . . internal monitoring processes.” The company says that it has not received reports of reportable adverse events for the 0.083% solution and that the lots met Nephron’s quality specifications when manufactured.
The lots involved in the recall are A3A33A, A3A33B, A3A34A, A3A35A, A3A36A, A3A37A, A3A38A, A3A40A, A3A41A, and A3A42A. Nephron has requested that retailers pull the lots from their shelves and is advising consumers to dispose of any inhalation solution from those lots.
The company added that it is “ready to work with every affected customer to ensure that the recall is not disruptive for the supply of this important drug product.”
Read the Nephron Pharmaceuticals press release.
